Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan 2021-12-10 12:17
I-Mab to Hold Investor Call to Present In-depth Clinical Data of Lemzoparlimab in Combination with Rituximab in Non-Hodgkins's Lymphoma 2021-12-09 21:00
I-Mab Announces First Patient Dosed in U.S. Phase 1 Study of Protollin for the Treatment of Alzheimer's Disease 2021-12-08 21:00
Nippon Express (Nederland) Acquires GDP Compliance Certification for Company-owned Warehouse 2021-12-08 14:00
China's Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, GenScript ProBio Expanding Manufacturing Capacity Again 2021-12-07 21:33
I-Mab to Pursue Dual Listing Plan on The Main Board of The Stock Exchange of Hong Kong Limited 2021-12-07 21:00
Samsung Biologics adds to global ISO certifications with Quality Management System 2021-12-07 13:04
Jacobio Receives IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China 2021-12-06 09:16
Kazia Announces Positive Final Data From Phase II Clinical Study Of Paxalisib In Newly Diagnosed Glioblastoma 2021-12-04 21:00
I-Mab Announces First Two Patients Dosed in U.S. Phase 2 Combination Trial of Uliledlimab with Atezolizumab in Patients with Selected Advanced Solid Tumors 2021-12-03 21:00
Biotheus' Bifunctional Therapeutic PM8001 has been Approved by the USFDA to Enter Phase II Studies 2021-12-03 16:23
InnoCare Announces Inclusion of Orelabrutinib in China National Reimbursement Drug List 2021-12-03 10:13
Hepagene Therapeutics Initiates the RISE Study, a Phase IIa Clinical Trial of HPG1860 in Patients with NASH 2021-12-02 23:00
MingMed Biotechnology Announces U.S. FDA Approval for IND Application of HPK1 Small Molecule Inhibitor PRJ1-3024, and Completion of Phase I Clinical Trials for Dry AMD Treatment Drug QA102 2021-12-02 22:00
Clarity and Cardinal Health enter into Agreement for Targeted Copper Theranostics 2021-12-02 21:58
Fifty percent recruitment milestone for PROPELLER prostate cancer trial 2021-12-01 21:57
Licensing Partner of Shenzhen Chipscreen Biosciences - HUYABIO International, Receives Regulatory Approval for Chidamide Monotherapy of Peripheral T-Cell Lymphoma(PTCL) in Japan 2021-12-01 21:54
Binhai New Area to spearhead China's medical industry development 2021-12-01 11:20
Ascentage Pharma and Innovent Biologics Announce Approval for China's First Third-Generation BCR-ABL TKI Olverembatinib, Marking a Clinical Breakthrough in the Treatment of Chronic Myeloid Leukemia 2021-12-01 08:00
Standigm signs MOU with Institut Pasteur Korea for AI-based drug discovery research on infectious disease 2021-11-30 21:30
1 90 91 92 93 94 165